Hiroko Oshima

11.3k total citations · 2 hit papers
87 papers, 8.2k citations indexed

About

Hiroko Oshima is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Hiroko Oshima has authored 87 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 36 papers in Oncology and 25 papers in Surgery. Recurrent topics in Hiroko Oshima's work include Helicobacter pylori-related gastroenterology studies (22 papers), Inflammatory mediators and NSAID effects (15 papers) and Genetic factors in colorectal cancer (14 papers). Hiroko Oshima is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (22 papers), Inflammatory mediators and NSAID effects (15 papers) and Genetic factors in colorectal cancer (14 papers). Hiroko Oshima collaborates with scholars based in Japan, United States and Australia. Hiroko Oshima's co-authors include Masanobu Oshima, Makoto M. Taketo, Jilly F. Evans, Bruno C. Hancock, James M. Trzăskos, Joseph Dinchuk, Elizabeth Kwong, Stacia Kargman, Masahiko Kobayashi and Kazuaki Takaku and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Hiroko Oshima

83 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

1996 2.0k citations Masanobu Oshima, Hiroko Oshima et al. profile →
TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesis

1996 540 citations Masanobu Oshima, Hiroko Oshima et al. Developmental Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroko Oshima Japan	40	4.0k	2.2k	2.2k	1.7k	1.6k	87	8.2k
Christos Paraskeva United Kingdom	46	4.4k 1.1×	1.2k 0.5×	2.8k 1.3×	2.3k 1.4×	1.2k 0.8×	112	8.5k
Masanobu Oshima Japan	56	6.9k 1.8×	3.1k 1.4×	4.3k 2.0×	2.8k 1.7×	2.8k 1.8×	154	14.3k
Hongmiao Sheng United States	37	2.4k 0.6×	3.2k 1.4×	1.4k 0.6×	1.2k 0.7×	2.0k 1.2×	56	6.1k
József Tı́már Hungary	50	4.0k 1.0×	760 0.3×	3.2k 1.5×	1.9k 1.1×	474 0.3×	328	8.4k
Hiroki Kuniyasu Japan	54	5.4k 1.4×	411 0.2×	3.1k 1.4×	2.2k 1.3×	645 0.4×	277	10.3k
Alane Koki United States	25	1.6k 0.4×	3.8k 1.7×	1.1k 0.5×	1.1k 0.6×	2.2k 1.4×	38	6.2k
Amy Moser United States	25	3.0k 0.8×	557 0.3×	2.0k 0.9×	1.0k 0.6×	1.2k 0.8×	42	5.4k
B. Mark Woerner United States	20	1.3k 0.3×	2.6k 1.2×	1.1k 0.5×	711 0.4×	1.5k 1.0×	21	4.8k
Alfred S.L. Cheng Hong Kong	51	5.4k 1.4×	464 0.2×	1.4k 0.6×	2.5k 1.5×	632 0.4×	146	8.2k
Lynn E. Heasley United States	50	6.0k 1.5×	561 0.3×	2.7k 1.2×	1.3k 0.8×	501 0.3×	141	9.2k

Countries citing papers authored by Hiroko Oshima

Since Specialization

Citations

This map shows the geographic impact of Hiroko Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Oshima more than expected).

Fields of papers citing papers by Hiroko Oshima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Oshima. The network helps show where Hiroko Oshima may publish in the future.

Co-authorship network of co-authors of Hiroko Oshima

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Oshima. A scholar is included among the top collaborators of Hiroko Oshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Oshima. Hiroko Oshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oshima, Hiroko, et al.. (2025). Characterizing for Subcellular Physical Property Changes of Chemotherapy Drug-Resistant Malignant Cancer Cells. Analytical Chemistry. 97(22). 11856–11862.

Nakayama, Mizuho, Hiroshi Saito, Kazuhiro Murakami, Hiroko Oshima, & Masanobu Oshima. (2024). Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway. Cancer Research Communications. 5(1). 13–23. 3 indexed citations

Nakayama, Mizuho, et al.. (2024). An In Vivo Metastasis Model Using Genotype-Defined Tumor Organoids. Methods in molecular biology. 2828. 57–68. 1 indexed citations

Hangai, Sho, Takeshi Kawamura, Yoshitaka Kimura, et al.. (2021). Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells. Nature Immunology. 22(8). 947–957. 46 indexed citations

Wang, Dong, Linhao Sun, Satoru Okuda, et al.. (2021). Nano-scale physical properties characteristic to metastatic intestinal cancer cells identified by high-speed scanning ion conductance microscope. Biomaterials. 280. 121256–121256. 15 indexed citations

Lim, Keesiang, Huajing Wang, Tuan Zea Tan, et al.. (2020). Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells. Journal of Biological Chemistry. 295(19). 6387–6400. 19 indexed citations

Echizen, Kanae, et al.. (2019). NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells. Oncogene. 38(22). 4250–4263. 59 indexed citations

Tsuji, Shunya, Kazuhiro Yoshimura, Masashi Sakurai, et al.. (2018). Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis. Molecular Cancer Research. 16(3). 554–563. 39 indexed citations

Han, Tae-Su, Dominic Chih‐Cheng Voon, Hiroko Oshima, et al.. (2018). Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice. Gastroenterology. 156(4). 1140–1155.e4. 45 indexed citations

10.

Tadokoro, Yuko, Takayuki Hoshii, Satoshi Yamazaki, et al.. (2018). Spred1 Safeguards Hematopoietic Homeostasis against Diet-Induced Systemic Stress. Cell stem cell. 22(5). 713–725.e8. 27 indexed citations

11.

Deswaerte, Virginie, Paul M. Nguyen, Alison C. West, et al.. (2017). Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism. Cancer Research. 78(5). 1293–1307. 66 indexed citations

12.

Kimura, Takeshi, Tsutomu Chiba, Hiroko Oshima, et al.. (2017). Nardilysin regulates inflammation, metaplasia, and tumors in murine stomach. Scientific Reports. 7(1). 43052–43052. 8 indexed citations

13.

Maeda, Yusuke, Kanae Echizen, Hiroko Oshima, et al.. (2016). Myeloid Differentiation Factor 88 Signaling in Bone Marrow–Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment. Cancer Prevention Research. 9(3). 253–263. 22 indexed citations

14.

Seishima, Ryo, T. Wada, Kenji Tsuchihashi, et al.. (2015). Ink4a/Arf -Dependent Loss of Parietal Cells Induced by Oxidative Stress Promotes CD44-Dependent Gastric Tumorigenesis. Cancer Prevention Research. 8(6). 492–501. 14 indexed citations

15.

Oshima, Hiroko, Mizuho Nakayama, Tae-Su Han, et al.. (2015). Suppressing TGFβ Signaling in Regenerating Epithelia in an Inflammatory Microenvironment Is Sufficient to Cause Invasive Intestinal Cancer. Cancer Research. 75(4). 766–776. 78 indexed citations

16.

Oshima, Hiroko, Hiraku Itadani, Hidehito Kotani, Makoto M. Taketo, & Masanobu Oshima. (2009). Induction of Prostaglandin E2 Pathway Promotes Gastric Hamartoma Development with Suppression of Bone Morphogenetic Protein Signaling. Cancer Research. 69(7). 2729–2733. 25 indexed citations

17.

Guo, Xiaoying, et al.. (2009). Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University). 145 indexed citations

18.

Guo, Xiao, et al.. (2008). Stromal Fibroblasts Activated by Tumor Cells Promote Angiogenesis in Mouse Gastric Cancer. Journal of Biological Chemistry. 283(28). 19864–19871.

19.

Shimizu, Yoshihiko, Dean Thumkeo, Toshimasa Ishizaki, et al.. (2005). ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. The Journal of Cell Biology. 168(6). 941–953. 258 indexed citations

20.

Oshima, Masanobu, Hiroko Oshima, & Makoto M. Taketo. (1996). TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesis. Developmental Biology. 179(1). 297–302. 540 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact